GlassScriptPhysician profile
Jerry I Huang
NPI 1083733943
$427,701.47
in general payments reported to CMS, 2019-2025
24 companies · $44K in 2025
The $44K reported for 2025 was more than what 98% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66K · 2020: $50K · 2021: $89K · 2022: $86K · 2023: $60K · 2024: $33K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $99K · Travel and Lodging: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,750 · Royalty Or License: $7,250 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,250 · Food and Beverage: $3,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $99,492.59 |
| Travel and Lodging | $16,179.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,750.00 |
| Royalty Or License | $7,250.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,250.00 |
| Food and Beverage | $3,094.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $207,459.34 | 2019-2025 | Acumed, Osteomed, Acumed |
| Arthrex, INC. | $82,915.41 | 2019-2022 | |
| Stryker Corporation | $32,889.03 | 2024-2025 | Variax, Gamma, Hoffmann |
| Encore Medical, LP | $30,631.18 | 2020-2022 | |
| Restor3d, INC. | $18,029.66 | 2021-2023 | |
| Medical Device Business Services, INC. | $10,314.76 | 2020-2021 | |
| Synthes USA Products LLC | $10,139.13 | 2022 | |
| Ossio INC | $8,991.83 | 2022-2024 | |
| Endo Pharmaceuticals INC. | $7,444.47 | 2019-2024 | Xiaflex |
| Synthes Gmbh | $6,053.09 | 2019-2025 | |
| Trice Medical, INC. | $4,400.00 | 2021 | |
| Summit Surgical Corp. | $2,423.04 | 2021 | |
| Integra Lifesciences Corporation | $2,250.00 | 2019 | |
| Trimed, INC. | $1,728.07 | 2020-2023 | |
| Intuitive Surgical, INC. | $685.00 | 2023 | Da Vinci Surgical System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $279.53 | 2020-2025 | Ijs, Geminus, Align |
| Medartis INC. | $236.92 | 2022-2024 | Aptus |
| Axogen | $207.90 | 2022 | |
| Lifenet Health | $147.35 | 2023 | |
| Zimmer Biomet Holdings, INC. | $126.81 | 2024 | A.L.P.S. |
| Endo USA, INC. | $125.00 | 2025 | Xiaflex |
| Abbvie INC. | $95.82 | 2025 | |
| Depuy Synthes Sales INC. | $86.51 | 2021-2022 | |
| Tenex Health INC. | $41.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9,315.65 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.